Navigation Links
Blood-Thinner Plavix Works Harder in Smokers
Date:8/4/2008

But the finding certainly isn't any reason to start or continue smoking, researchers say

MONDAY, Aug. 4 (HealthDay News) -- The widely used anti-clotting drug Plavix appears to have a stronger effect in people who smoke, a study indicates.

Plavix (clopidogrel) is often given to heart attack patients after the attack. It inhibits formation of clots by blood cells called platelets.

The study of 259 people given Plavix because of coronary conditions found that those who smoked had significantly less clot formation than nonsmokers.

But it's still too early to say that doctors should include smoking among the factors that affect whether Plavix should be prescribed or how large the dose should be, said study lead author Dr. Paul A. Gurbel, associate professor of medicine at Johns Hopkins University and director of the Sinai Center for Thrombosis Research, Baltimore.

"I don't know if we can jump to that conclusion yet," Gurbel said. "We need to study this further. We do know from two large-scale clinical trials that smokers benefited more when they got Plavix therapy. Maybe smoking does something to make Plavix work better."

That "something" probably occurs in the liver, where the drug is metabolized, Gurbel said. Cigarette smoking increases the production of CYP1A2, a liver enzyme that converts the drug to its active form, he said.

"Current smoking was an independent predictor of low platelet aggregation," the journal report said.

Of course, lower clotting action can sometimes mean a higher risk for bleeding. But Gurbel said that, based on these early findings, "we don't know if [smoking patients] will bleed more."

The findings were expected to be published in the Aug. 12 issue of the Journal of the American College of Cardiology.

Plavix is widely used to prevent coronary problems and is commonly prescribed after a heart attack. A standard recommendation
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Blood-Thinner No Help for Dialysis Treatment
2. Blood-Thinner Contaminant Traced to Chinese Plant
3. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
4. First 90 Days After Stopping Plavix Most Dangerous
5. Once-Daily Combo Works for New HIV Patients
6. Plexus Consulting Group Works With a USAID-Funded Project to Help the Private Hospitals Association of Jordan Create a Roadmap for the Future
7. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
8. DIA And FDA To Host Two Important Critical Path Workshops
9. Autisms social struggles due to disrupted communication networks in brain
10. Ceridian LifeWorks Offers CareGiverHelper Service to Clients to Ease Stress of Family Caregiving
11. Workshop Helps Parents, Kids Talk About Sex
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood-Thinner Plavix Works Harder in Smokers
Blood-Thinner Plavix Works Harder in Smokers
Breaking Medicine Technology:Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 1NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 2NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 3Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 1Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 1President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 3President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 4